Cancer clinical trials in the region Auvergne-Rhône-Alpes

445 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Phase 3 Penile cancer and germ cell tumors #NCT05874063 #2022-502426-41-00
Germ cell tumor None Systemic Treatment-Naive Systemic Treatment-Naive Good prognosis Intermediate prognosis
18 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Lung cancer #NCT07099898 #2025-521627-78
SCLC (Small Cell Lung Cancer) Locally Advanced Metastatic 1 Immunotherapy Chemotherapy
3 recruiting sites
GlaxoSmithKline
Phase 3 Head and neck cancer #NCT06525220 #2023-510323-30-00
Oral cavity Oropharynx Hypopharynx Larynx Squamous cell carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive CPS Positive (1 <= X < 20) CPS Positive (X >= 20)
14 recruiting sites
Merus
Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT06545955
Non-invasive bladder cancer Urothelial carcinoma Localized 1 Surgery Immunotherapy
Systemic Treatment-Naive
9 recruiting sites
Ferring Pharmaceuticals